PL3768248T3 - Stała tabletka farmaceutyczna - Google Patents

Stała tabletka farmaceutyczna

Info

Publication number
PL3768248T3
PL3768248T3 PL19714544.4T PL19714544T PL3768248T3 PL 3768248 T3 PL3768248 T3 PL 3768248T3 PL 19714544 T PL19714544 T PL 19714544T PL 3768248 T3 PL3768248 T3 PL 3768248T3
Authority
PL
Poland
Prior art keywords
solid pharmaceutical
pharmaceutical tablet
tablet
solid
pharmaceutical
Prior art date
Application number
PL19714544.4T
Other languages
English (en)
Inventor
Jesper Neergaard
Original Assignee
Fertin Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma A/S filed Critical Fertin Pharma A/S
Publication of PL3768248T3 publication Critical patent/PL3768248T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19714544.4T 2018-03-23 2019-03-21 Stała tabletka farmaceutyczna PL3768248T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/933,942 US10980831B2 (en) 2018-03-23 2018-03-23 Solid pharmaceutical tablet
PCT/DK2019/050100 WO2019179589A1 (en) 2018-03-23 2019-03-21 A solid pharmaceutical tablet

Publications (1)

Publication Number Publication Date
PL3768248T3 true PL3768248T3 (pl) 2023-08-28

Family

ID=65995450

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19714544.4T PL3768248T3 (pl) 2018-03-23 2019-03-21 Stała tabletka farmaceutyczna

Country Status (10)

Country Link
US (3) US10980831B2 (pl)
EP (2) EP3768248B1 (pl)
JP (1) JP7303211B2 (pl)
CN (1) CN111902135A (pl)
AU (2) AU2019239514B2 (pl)
BR (1) BR112020018025A2 (pl)
CA (1) CA3094737A1 (pl)
ES (1) ES2951267T3 (pl)
PL (1) PL3768248T3 (pl)
WO (1) WO2019179589A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025230986A1 (en) * 2024-04-29 2025-11-06 Anju Majeed Aqueous dispersion of molecules-process, formulation and method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4753805A (en) 1984-01-31 1988-06-28 Warner-Lambert Company Tabletted chewing gum composition and method of preparation
ZA87994B (en) 1986-02-27 1987-09-30 Warner Lambert Co Antacid chewing gum
JPH0695888B2 (ja) * 1989-10-18 1994-11-30 株式会社サンギ カルシウム補給用チューインガム
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO2000062762A1 (en) 1999-04-15 2000-10-26 Wm. Wrigley Jr. Company Chewing gum with dental benefits including calcium in a food grade acid
US7244455B2 (en) 2002-01-16 2007-07-17 Warner-Lambert Company Center-filled chewing gum containing a deliverable form of calcium
EP1495680A1 (en) 2003-07-08 2005-01-12 Gum Base Co. S.p.A. Gum base for chewing gum
WO2006000233A1 (en) * 2004-06-29 2006-01-05 Fertin Pharma A/S Tobacco alkaloid containing chewing gum
DK1765304T4 (da) * 2004-07-06 2019-06-03 Fertin Pharma As Komprimattyggegummitablet
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
EP2124600A1 (en) 2007-02-26 2009-12-02 Revolymer Limited Medicated chewing gum
WO2015070875A1 (en) 2013-11-15 2015-05-21 Fertin Pharma A/S Chewing gum suitable for diabetics
US10426726B2 (en) * 2014-04-08 2019-10-01 Fertin Pharma A/S Medical chewing gum
GB2542192A (en) * 2015-09-11 2017-03-15 Revolymer (Uk) Ltd Chewable medicament
US10485247B2 (en) 2015-10-07 2019-11-26 Fertin Pharma A/S Chewing gum comprising nicotine
ITUA20163230A1 (it) * 2016-05-06 2017-11-06 Perfetti Van Melle Spa Gomma da masticare con stevia
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers

Also Published As

Publication number Publication date
CA3094737A1 (en) 2019-09-26
AU2019239514B2 (en) 2024-02-01
US20190290684A1 (en) 2019-09-26
US20210205355A1 (en) 2021-07-08
EP3831368A1 (en) 2021-06-09
JP7303211B2 (ja) 2023-07-04
ES2951267T3 (es) 2023-10-19
US10980831B2 (en) 2021-04-20
EP3768248B1 (en) 2023-06-14
US11723918B2 (en) 2023-08-15
BR112020018025A2 (pt) 2020-12-22
EP3768248A1 (en) 2021-01-27
WO2019179589A1 (en) 2019-09-26
US20210023128A1 (en) 2021-01-28
AU2024202892A1 (en) 2024-05-23
AU2024202892B2 (en) 2025-01-16
US11730757B2 (en) 2023-08-22
EP3768248C0 (en) 2023-06-14
AU2019239514A1 (en) 2020-10-29
JP2021518412A (ja) 2021-08-02
CN111902135A (zh) 2020-11-06

Similar Documents

Publication Publication Date Title
IL276232A (en) pharmaceutical compounds
GB2572126B (en) Pharmaceutical
GB2569961B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201706327D0 (en) A pharmaceutical compound
GB201810245D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
IL256299A (en) Immediate-release tablets containing drug and processes for creating the tablets
GB201810239D0 (en) Pharmaceutical compounds
GB201819960D0 (en) Pharmaceutical compounds
PL4003293T3 (pl) Rozwój farmaceutyczny
IL273704A (en) Pharmaceutical bilayer tablet formulations
GB201801562D0 (en) Pharmaceutical compounds
IL277334A (en) Pharmaceutical combinations
GB201800378D0 (en) Pharmaceutical compounds
IL279334A (en) Pharmaceutical combinations
GB201816369D0 (en) Pharmaceutical compounds
GB201816716D0 (en) A tablet
GB201816714D0 (en) A tablet
CA200107S (en) Pharmaceutical tablet
CA199173S (en) Pharmaceutical tablet
CA199175S (en) Pharmaceutical tablet
CA199170S (en) Pharmaceutical tablet
PH32017000907S1 (en) Pharmaceutical tablets
AP00977S1 (en) Pharmaceutical tablets